Stockreport

Intron Health's Naresh Chouhan explains why he's downgrading Novo Nordisk from buy to sell [CNBC]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Naresh Chouhan, Intron Health principal, joins 'Squawk Box' to discuss why he's downgrading Novo Nordisk from buy to sell and slashing the target price. [Read more]